Shufang Renault
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 11
- Otorhinolaryngology top 10%
-
- Pancreatic and Hepatic Oncology Research 2
-
- Genetic factors in colorectal cancer 2
-
- Advanced Breast Cancer Therapies 3
- Renal cell carcinoma treatment 2
-
- Epigenetics and DNA Methylation 2
-
- Salivary Gland Disorders and Functions 2
-
- Diabetes and associated disorders 2
- Co-authors
- Valérie TalyPierre Laurent‐PuigJörg TostGaëtane NocturneSaida BoudaoudXavier MarietteFrançois‐Clément BidardCaroline Hego
- Partner nations
- FranceDenmarkUnited States
In The Last Decade
Shufang Renault
16 papers receiving 677 citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Cancer Research 322
- Otorhinolaryngology 39
- Oncology 210
- Immunology 161
- Pathology and Forensic Medicine 75
Countries citing papers authored by Shufang Renault
This map shows the geographic impact of Shufang Renault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufang Renault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufang Renault more than expected).
Fields of papers citing papers by Shufang Renault
This network shows the impact of papers produced by Shufang Renault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufang Renault. The network helps show where Shufang Renault may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shufang Renault, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 12 | |
| 3 | 2024 | 6 | |
| 4 | Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activationbreakdown → | 2023 | 148 |
| 5 | 2023 | 1 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 12 | |
| 9 | 2021 | 33 | |
| 10 | 2020 | 10 | |
| 11 | 2019 | 73 | |
| 12 | 2019 | 3 | |
| 13 | 2019 | 32 | |
| 14 | 2017 | 6 | |
| 15 | 2017 | 78 | |
| 16 | 2017 | 186 | |
| 17 | 2015 | 72 |
About Shufang Renault
Shufang Renault is a scholar working on Cancer Research, Oncology and Otorhinolaryngology, having authored 17 papers that have together received 683 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (11 papers), Advanced Breast Cancer Therapies (3 papers), Renal cell carcinoma treatment (2 papers), Epigenetics and DNA Methylation (2 papers), Genetic factors in colorectal cancer (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Salivary Gland Disorders and Functions (2 papers) and Diabetes and associated disorders (2 papers). The work is most often cited by research in Cancer Research (322 citations), Otorhinolaryngology (39 citations) and Oncology (210 citations). Shufang Renault has collaborated with scholars based in France, Denmark and United States. Frequent co-authors include Valérie Taly, Pierre Laurent‐Puig, Jörg Tost, Gaëtane Nocturne, Saida Boudaoud, Xavier Mariette, François‐Clément Bidard, Caroline Hego, Victor Renault and Géraldine Rios. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.